NCT06960902View on ClinicalTrials.gov

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

March 25, 2027

Study Completion Date

September 25, 2029

Conditions
Familial HypercholesterolemiasAtherosclerotic Cardiovascular Disease (ASCVD)
Interventions
OTHER

Coronary CT scan with CAC score measurement

Coronary CT scan with CAC score measurement (on the same day or within 6 months after the inclusion visit).

Trial Locations (9)

Unknown

NOT_YET_RECRUITING

CHU Dijon Bourgogne, Dijon

NOT_YET_RECRUITING

CHRU Lille, Lille

NOT_YET_RECRUITING

Hospices Civils de Lyon, Lyon

NOT_YET_RECRUITING

Hôpital de la Conception, AP-HM, Marseille

RECRUITING

CHU Nantes, Nantes

NOT_YET_RECRUITING

Hôpital de la Pitié-Salpêtrière, AP-HP, Paris

NOT_YET_RECRUITING

Hôpital Saint-Antoine, AP-HP, Paris

NOT_YET_RECRUITING

CHU Rennes, Rennes

NOT_YET_RECRUITING

CHU Strasbourg, Strasbourg

All Listed Sponsors
collaborator

France 2030 program

UNKNOWN

collaborator

European Union Next Generation

UNKNOWN

lead

Nantes University Hospital

OTHER